The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...
As Incyte strives to push its topical JAK inhibitor Opzelura into additional dermatology indications, the company’s latest ...
Zacks Investment Research on MSN1h
INCY Opzelura Shows Superior Efficacy in 2 Prurigo Nodularis StudiesIncyte INCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ...
Shawn Kwatra, MD, FAAD, physician scientist at the University of Maryland Medical System, presented data at the American Academy of Dermatology 2025 annual conference on the rapid efficacy of topical ...
Abrocitinib was efficacious and safe in patients with atopic dermatitis who did and who did not respond to prior treatment with dupilumab.
Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...
Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback